Research Topics
| Jenny MortonSummaryAffiliation: University of Cambridge Country: UK Publications
| Collaborators
|
Detail Information
Publications
Ecstasy: pharmacology and neurotoxicityJenny Morton
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
Curr Opin Pharmacol 5:79-86. 2005....
Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicityA J Morton
Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom
Brain Res Bull 52:51-9. 2000..The significance of these findings is discussed in the context of the R6/2 mouse as a model for HD...
Executive decision-making in the domestic sheepA Jennifer Morton
Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom
PLoS ONE 6:e15752. 2011..Sheep have great potential, not only for use as a large animal model of HD, but also for studying cognitive function and the evolution of complex behaviours in normal animals...
A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's diseaseA Jennifer Morton
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1 PD, UK
Eur J Neurosci 21:855-70. 2005..Our study shows that cognitive decline caused by a genetic mutation can be slowed by a combination drug treatment, and gives hope that cognitive symptoms in HD can be treated...
Progressive depletion of complexin II in a transgenic mouse model of Huntington's diseaseA J Morton
Department of Pharmacology, University of Cambridge, Cambridge, UK
J Neurochem 76:166-72. 2001..Our results suggest that changes in neurotransmitter release might contribute to the neuronal dysfunction seen in these mice...
Abnormalities in the synaptic vesicle fusion machinery in Huntington's diseaseA J Morton
Department of Pharmacology, University of Cambridge, Cambridge, UK
Brain Res Bull 56:111-7. 2001....
Disintegration of the sleep-wake cycle and circadian timing in Huntington's diseaseA Jennifer Morton
Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, United Kingdom
J Neurosci 25:157-63. 2005..We propose that circadian sleep disturbances are an important pathological feature of HD, that they arise from pathology within the SCN molecular oscillation, and that their treatment will bring appreciable benefits to HD patients...
Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 miceA Jennifer Morton
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
Neurobiol Dis 33:331-41. 2009..This mouse may represent a better model for adult-onset HD than R6/2 mice with shorter repeats...
Complexin II is essential for normal neurological function in miceDervila Glynn
Department of Pharmacology, University of Cambridge, UK
Hum Mol Genet 12:2431-48. 2003..Given that decreased expression of CPLXII is seen in HD and schizophrenic patients, a role for CPLXII depletion should be considered in other diseases where motor, cognitive and psychiatric symptoms co-exist...
Profound ataxia in complexin I knockout mice masks a complex phenotype that includes exploratory and habituation deficitsDervila Glynn
Department of Pharmacology, University of Cambridge, UK
Hum Mol Genet 14:2369-85. 2005..These results support the idea that altered expression of complexins in disease states may contribute to the symptomatology of disorders in which they are dysregulated...
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's diseaseMiriam A Hickey
Department of Pharmacology, University of Cambridge, UK
J Neurochem 81:46-59. 2002..These results suggest that dysfunctional DA neurotransmission contributes to phenotype development in R6/2 mice and thus also may be important in symptom progression in HD...
Olfactory abnormalities in Huntington's disease: decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patientsStanley E Lazic
Centre for Brain Repair, University of Cambridge, CB2 2PY, UK
Brain Res 1151:219-26. 2007..These results suggest that olfactory impairments observed in HD patients may be the result of reduced plasticity in the primary olfactory cortex...
Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutationWhitney Freeman
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
Brain Res Bull 63:45-55. 2004..We suggest that downregulation of expression of mRNA encoding SNARE-associated proteins, first CPLXII and later CPLXI and alpha-SNAP, contributes to the progressive neuropathology of the R6/2 mouse model of Huntington's disease...
Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's diseaseJonathan Wanderer
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK
Histochem Cell Biol 127:473-84. 2007..Their role in the pathogenesis of HD is likely to depend on their location as well as their composition...
Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's diseaseAlessandro Ciamei
Department of Pharmacology, University of Cambridge, Cambridge, UK
Neurobiol Learn Mem 92:417-28. 2009..We conclude that following striatal decline in R6/2 mice between 8 and 12 weeks of age, hippocampal functions emerge to drive the escape response of R6/2 mice...
Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feedingElizabeth S Maywood
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom
J Neurosci 30:10199-204. 2010..Thus, even subtle imbalances in liver function may exacerbate symptoms of HD, where neurological function is already compromised...
Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normalCheney J G Drew
Department of Pharmacology, University fo Cambridge, UK
Hum Mol Genet 16:2288-305. 2007..Abnormalities in complexin 1 levels in the brain may therefore contribute to the psycho-social aspects of human diseases in which this protein is dysregulated...
Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's diseasePatrick N Pallier
Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, United Kingdom
J Neurosci 27:7869-78. 2007....
Systemic administration of Congo red does not improve motor or cognitive function in R6/2 miceNigel I Wood
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
Neurobiol Dis 25:342-53. 2007..We suggest that this is due to the inability of Congo red to cross the blood-brain barrier. Since it does not improve the behavioural deterioration that is a key feature of HD, Congo red is unlikely to be useful as a therapy for HD...
Mice transgenic for the Huntington's disease mutation are resistant to chronic 3-nitropropionic acid-induced striatal toxicityM A Hickey
Department of Pharmacology, University of Cambridge, Cambridge, England
J Neurochem 75:2163-71. 2000..The existence of similar compensatory mechanisms may explain why, in humans, HD is a late-onset disorder, despite early expression of the genetic mutation...
The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor functionPatrick N Pallier
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom
Brain Res Bull 78:347-55. 2009....
A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouseHelen E Gibson
Department of Anatomy, University of Cambridge, Downing Street, Cambridge CB2 3DY, UK
Eur J Neurosci 22:1701-12. 2005..This impairment in MF LTP could contribute to spatial learning deficits observed in R6/2 and Cplx2-/- mice...
Early motor development is abnormal in complexin 1 knockout miceDervila Glynn
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
Neurobiol Dis 25:483-95. 2007..A role for complexin I depletion should be considered in diseases where deficits in early sensory and motor development exist, such as autism and schizophrenia...
Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutationAnna Wade
Department of Pharmacology, University of Cambridge, Cambridge, UK
Brain Res 1188:61-8. 2008..We suggest that degenerative changes in axons are likely to contribute to the early pathological phenotype in HD, even in the absence of frank neuronal cell loss...
Management of sleep/wake cycles improves cognitive function in a transgenic mouse model of Huntington's diseasePatrick N Pallier
Department of Pharmacology, University of Cambridge, Cambridge, UK
Brain Res 1279:90-8. 2009..We suggest that focused management of sleep and wakefulness will slow the progression of cognitive decline and apathy in neurological conditions where sleep is disordered...
Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin IIJ Michael Edwardson
Department of Pharmacology, Tennis Court Road, Cambridge CB2 1PD, United Kingdom
J Biol Chem 278:30849-53. 2003..Complexin II depletion in the brain may account for some of the abnormalities in neurotransmission associated with HD...
Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutationDavid Hernandez-Espinosa
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, United Kingdom
Brain Res Bull 69:669-79. 2006..Together, our data suggest a central role for CaN in the deleterious phenotype of the R6/2 mouse. Treatments aimed at preventing the loss of CaN or stimulating its function may be beneficial in the treatment of HD...
Differential messenger RNA expression of complexins in mouse brainWhitney Freeman
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
Brain Res Bull 63:33-44. 2004....
Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutationK P Murphy
Department of Pharmacology, Centre for Brain Repair, Parke Davis Neuroscience Research, Department of Experimental Psychology, University of Cambridge, CB2 1QJ, United Kingdom
J Neurosci 20:5115-23. 2000..The temporal and regional changes in synaptic plasticity within the hippocampus mirror the appearance of neuronal intranuclear inclusions, suggesting a relationship between polyglutamine aggregation and dysfunction...
Increased thirst and drinking in Huntington's disease and the R6/2 mouseNigel I Wood
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom
Brain Res Bull 76:70-9. 2008..We suggest that increased thirst may be an important and clinically relevant biomarker for the study of disease progression in HD...
Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agentsMark J Hunt
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK
Exp Brain Res 166:220-9. 2005..However, chronic treatment with these hypoglycaemic agents had no effect on either the course of the diabetes or the disease in R6/2 mice...
Clorgyline-mediated reversal of neurological deficits in a Complexin 2 knockout mouseDervila Glynn
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
Hum Mol Genet 19:3402-12. 2010....
Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's diseaseV W S Kung
Department of Physiology, Development and Neuroscience, Anatomy School, University of Cambridge, Downing Street, Cambridge CB2 3DY, UK
Neuroscience 146:1571-80. 2007..As dopamine-dependent plasticity is a proposed model of striatum-based motor and cognitive functions, this impairment could contribute to deficits seen in R6/2 mice...
Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometryS J Sawiak
Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke s Hospital, Cambridge, UK
Neurobiol Dis 33:20-7. 2009..These data indicate that VBM will be a valuable technique for in vivo measurement of developing pathology in HD transgenic mice, and may be particularly useful for correlating histologically undetectable changes with behavioral deficits...
Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's diseaseS J Sawiak
Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke s Hospital, Cambridge, UK
Neurobiol Dis 33:12-9. 2009..Having obtained proof-of-principle for the technique using ex vivo tissue, it is now our intention to carry out in vivo measurement of developing pathology in HD transgenic mice, and correlate this with behavioral deficits...
Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's diseaseNigel I Wood
Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom
PLoS ONE 5:e9077. 2010..We have also shown previously that HD patients and R6/2 mice have disrupted circadian rhythms, treatment of which may improve cognition, general health, and survival...
Asymptomatic sleep abnormalities are a common early feature in patients with Huntington's diseaseAnna O G Goodman
Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, Addenbrooke s Hospital, Hills Road, Cambridge, CB2 0QQ, United Kingdom
Curr Neurol Neurosci Rep 11:211-7. 2011..These results suggest that although marked changes in sleep architecture are present in early HD and can be detected using polysomnography, patients do not necessarily recognize or report these abnormalities...
The touchscreen cognitive testing method for rodents: how to get the best out of your ratTimothy J Bussey
Department of Experimental Psychology, University of Cambridge, Cambridge CB2 3EB, United Kingdom
Learn Mem 15:516-23. 2008..Taken together, these experiments served to optimize the touchscreen method and have demonstrated its usefulness as a high-throughput method for the cognitive testing of rodents...
Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington's disease mutationNigel I Wood
Department of Pharmacology, University of Cambridge, Tennis Court Road, CB2 1PD Cambridge, UK
Brain Res Bull 61:375-83. 2003..The improvement in rotarod performance suggests that lithium may improve motor symptoms as well as depression in some HD patients...
The metabolic profile of early Huntington's disease--a combined human and transgenic mouse studyAnna O G Goodman
Cambridge Centre for Brain Repair, E D Adrian Building, Forvie Site, Robinson Way, Cambridge, CB2 2PY, UK
Exp Neurol 210:691-8. 2008..The reason for this is not known but may reflect a catabolic state secondary to hypothalamic pathology, as abnormalities have been reported in the hypothalamus early in the disease course...
Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironmentWendy Phillips
Cambridge Centre for Brain Repair, Cambridge CB2 2PY, United Kingdom
J Neurosci 25:11564-76. 2005..These results suggest that abnormal neurogenesis in the R6/2 mouse is not attributable to an intrinsic impairment of the NPC itself but is attributable to the environment in which the cell is located...
Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HDDervila Glynn
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, UK
Brain Res Bull 72:108-20. 2007..This indicates that loss of complexin II is part of the mechanism underlying the R6/2 phenotype. Whether it is causal or compensatory remains to be determined...
Limbic neurogenesis/plasticity in the R6/2 mouse model of Huntington's diseaseWendy Phillips
Cambridge Centre for Brain Repair, Addenbrooke s Hospital, Cambridge, UK
Neuroreport 17:1623-7. 2006..These results support the possibility that impaired neurogenesis and/or plasticity could contribute to cognitive and psychiatric impairments in Huntington's disease...
Rigidity in social and emotional memory in the R6/2 mouse model of Huntington's diseaseAlessandro Ciamei
Department of Pharmacology, University of Cambridge, Tennis Court Road, CB2 1PD Cambridge, UK
Neurobiol Learn Mem 89:533-44. 2008..Further, social and emotional memories appear to be encoded in a rigid way that is not influenced by subsequent learning or by arousal levels...
Time-lapse analysis of aggregate formation in an inducible PC12 cell model of Huntington's disease reveals time-dependent aggregate formation that transiently delays cell deathB Gong
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
Brain Res Bull 75:146-57. 2008..Together our data are compatible with a toxic role for aggregates/aggregation and support the 'toxic precursor' hypothesis. However, they also suggest that at some stages, the process of aggregate formation is cytoprotective...
Methamphetamine toxicity in mice is potentiated by exposure to loud musicA J Morton
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, UK
Neuroreport 12:3277-81. 2001..A greater increase in reactive gliosis was also seen after exposure to METH and loud music. Thus, METH appears to be more toxic when taken while exposed to loud music...
Endothelins induce Fos expression in neurons and glia in organotypic cultures of rat cerebellumA M Sullivan
Department of Pharmacology, University of Cambridge, England
J Neurochem 67:1409-18. 1996..It appears likely that ETs play an important neuromodulatory role in the cerebellum...
Syncollin is required for efficient zymogen granule exocytosisBarbara Wäsle
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
Biochem J 385:721-7. 2005..We conclude that syncollin is required for efficient exocytosis in the pancreatic acinar cell, and that it plays a particularly important role in compound exocytosis...
Microglia density decreases with age in a mouse model of Huntington's diseaseLi Ma
Department of Anatomy with Radiology, University of Auckland, Auckland, New Zealand
Glia 43:274-80. 2003..Such changes in the dynamic status of microglia may lead to an impairment of their neurosupportive functions. Further studies are needed to understand better the role of microglia in aging and neurodegeneration...
Increased metabolism in the R6/2 mouse model of Huntington's diseaseJorien M M van der Burg
Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University BMC A10, Lund, Sweden
Neurobiol Dis 29:41-51. 2008..Together, these data demonstrate that weight loss in R6/2 mice is associated with increased metabolism and changes in several weight-regulating factors...
Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutationRichard R Ribchester
Division of Neuroscience, University of Edinburgh, George Square, Edinburgh EH8 9JZ, UK
Eur J Neurosci 20:3092-114. 2004..However, irrespective of the cause, the abnormalities at neuromuscular junctions we report here are likely to contribute to the pathological phenotype in R6/2 mice, particularly in late stages of the disease...
Measuring cognitive deficits in disabled mice using an automated interactive touchscreen systemA Jennifer Morton
Nat Methods 3:767. 2006
